Prostate cancer under a magnifying glass

Today, through the perineal route at the level of the small pelvis, non-invasive biopsies with ultrasound and MRI can be performed to make a more accurate diagnosis of prostate cancer pathology. Classically, to diagnose an abnormality (cancer or benign tumor) of the prostate, a urologist takes a sample (biopsy) rectally.

Psychologically, it is still traumatic in our Moroccan context. Men will lose a lot of time due to this obstacle. Fortunately, science is evolving. Today, ultrasound- and MRI-guided non-invasive biopsies can be performed via the perineal route at the level of the small pelvis.

Morocco is just in time for this latest medical development. The Department of Urology of the Mohammed V Military Instruction Hospital and the Moroccan Group of Andrology and Sexual Medicine (GRAMS) are organizing this Friday, September 23, 2022 in Rabat, a scientific meeting on diagnostic and therapeutic innovations in prostate cancer.

This continuing medical education meeting on one of the most common urologic pathologies will benefit from the expertise of a specialized team at the Urology Institute of Nantes-Atlantis, led by Dr. Thierry Rousseau. The Nantes Medical Group presents many years of experience in the diagnosis of prostate cancer using a non-invasive technique called “transperineal prostate biopsy and image fusion”.

Moroccan urologists from the public, private and military sectors will participate in workshops on this new prostate biopsy technique led by Dr. Thierry Rousseau’s Nantes urology team. This innovative technology in image-assisted urology, focused on prostate cancer, has a major challenge in bringing the quality and accuracy of minimally invasive interventions to the diagnosis and treatment stages of the most common cancers in humans.

This surgical gesture aid directs the doctor to the suspicious area during the biopsy, recording the cartography of the biopsies for better quality control. One of the originalities of his approach is the real-time integration of MRI and ultrasound data into a single image. Two imaging techniques that require conditions that are usually incompatible and therefore cannot be performed simultaneously in a patient.

For the first time, 3D ultrasound, image fusion and organ monitoring are combined in a unique and intuitive device that allows the urologist to control the accuracy and quality of the prostate biopsy and allow the selection of treatment adapted to each patient. It is important to clarify that prostate cancer is the first cancer in men and corresponds to the second cause of cancer death. This is a major public health concern, especially given the increase in life expectancy. If its screening is based on PSA blood test and clinical examination (digital examination), its diagnosis requires histological analysis of prostate samples.

Currently, in clinical routine, these prostate biopsies are performed endorectally under ultrasound guidance. Most often, the cancer is not visible on the ultrasound image, and it is used to take a dozen samples (or carrots), which are distributed as best as possible on the prostate.

To increase the accuracy and contribution of these biopsies, the use of data obtained by magnetic resonance imaging (MRI), as well as the fusion of ultrasound and MRI images, is currently a therapy in the process of validation and is performed in many. Institutions with special tools.

The aim of the meeting between the urologists of Rabat, Kenitri and Nantes is to present the practical methods of performing this prostate biopsy using image fusion in Morocco and to discuss the advantages and benefits. The scientific meeting on new diagnostic and treatment technologies in urology between Nantes and Rabat urologists will also focus on robotic laparoscopic techniques, urinary incontinence and prolapse surgery in women, perineal vaginal surgery with bands or sacral neuromodulation.».

Leave a Comment

Your email address will not be published.